Knight Deja, Saleem Haneefa, Baral Stefan, German Danielle, Willie Tiara C
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.
BMC Public Health. 2025 Jul 29;25(1):2579. doi: 10.1186/s12889-025-23775-0.
Black cisgender women are disproportionately affected by HIV across the United States (US). Moreover, emerging adults continue to be significantly affected compared to women in older age groups. Yet in 2024, Black cisgender women and emerging adult women comprise a small fraction of HIV pre-exposure prophylaxis (PrEP) users in the US. This study examined PrEP modality, service delivery, and marketing and communication preferences by age among Black cisgender women in Baltimore, Maryland.
Between October 2021 and April 2023, twelve Black cisgender PrEP-inexperienced emerging (18 to 29 years) and fourteen older (30 to 44 years) adult women were purposively recruited to participate in an in-depth interview. Interview topics included PrEP modality, service delivery, and marketing and communication preferences among the two currently approved modalities (oral and injectable) and the two modalities under investigation (ring and implant). Interviews were audio-recorded, transcribed verbatim, and analyzed using a combination of a deductive and inductive approaches. Six follow-up interviews were also conducted.
Emerging adult women preferred oral PrEP, but older adult women preferred long-acting injectable (LAI) forms of PrEP. Oral PrEP was preferred because it was considered the most common modality for other medications, whereas LAI was preferred because it didn't necessitate daily administration. Emerging Black adult women reported their challenges with adhering to the routine PrEP three-month follow-up period, such as transportation, scheduling appointments, conflicts with school engagements, and being in a period of transition into adulthood where they experience structural changes (e.g., health insurance). Transportation was the only reported challenge for older adult women for follow-up. Both age groups preferred longer follow-up periods to refill their PrEP prescriptions and to obtain PrEP from a trusted physician (e.g., OBGYN). Both groups of Black women expressed a preference for PrEP to be advertised through diverse means including social media campaigns, sexual health forums, peer groups on college campuses, and by featuring Black women in PrEP commercials.
To improve PrEP equity and initiation of current and emerging PrEP modalities, it is crucial to integrate the lived experiences and preferences of Black cisgender women and enhance their representation in PrEP messaging.
在美国,黑人顺性别女性感染艾滋病毒的比例过高。此外,与老年女性相比,新兴成年女性仍然受到显著影响。然而,在2024年,黑人顺性别女性和新兴成年女性在美国艾滋病毒暴露前预防(PrEP)使用者中所占比例很小。本研究调查了马里兰州巴尔的摩市黑人顺性别女性按年龄划分的PrEP方式、服务提供以及营销和沟通偏好。
在2021年10月至2023年4月期间,有目的地招募了12名没有PrEP经验的新兴黑人(18至29岁)成年女性和14名年龄较大(30至44岁)的成年女性参与深入访谈。访谈主题包括PrEP方式、服务提供以及在两种目前已获批的方式(口服和注射)和两种正在研究的方式(阴道环和植入剂)中的营销和沟通偏好。访谈进行了录音,逐字转录,并采用演绎和归纳相结合的方法进行分析。还进行了6次随访访谈。
新兴成年女性更喜欢口服PrEP,但年龄较大的成年女性更喜欢长效注射(LAI)形式的PrEP。选择口服PrEP是因为它被认为是其他药物最常见的方式,而选择LAI是因为它无需每日给药。新兴黑人成年女性报告了她们在坚持PrEP三个月常规随访期方面面临的挑战,比如交通、预约安排、与学业安排冲突以及处于向成年过渡阶段,在此期间她们经历结构变化(如医疗保险)。交通是年龄较大成年女性随访中唯一报告的挑战。两个年龄组都希望有更长的随访期来补充她们的PrEP处方,并从值得信赖的医生(如妇产科医生)那里获得PrEP。两组黑人女性都表示倾向于通过多种方式宣传PrEP,包括社交媒体活动、性健康论坛、大学校园的同伴群体以及在PrEP广告中展示黑人女性形象。
为了提高PrEP公平性以及启动当前和新兴的PrEP方式,整合黑人顺性别女性的生活经历和偏好并增强她们在PrEP宣传信息中的代表性至关重要。